AUM LifeTech, Inc.

AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform in the gene silencing and regulation space. Our mission is to leverage the power and adaptability of our unique FANA ASO RNA silencing technology to treat and find a cure some for genetically defined diseases. In order to do so, our technology relies on one of the most important molecules in the body: RNA. AUM LifeTech’s FANA ASO RNA silencing technology holds the key to successful development of Nucleic Acid Therapeutics. Our goal is to successfully address some of the challenges in therapeutic development using our next-generation FANA ASO RNA silencing technology. In doing so, we aim to bring discoveries to the clinic in a timely manner. AUM’s RNA silencing and regulation technology can be used to very efficiently target and silence a variety of RNA modalities, including mRNA, microRNA, and long non-coding RNA. AUM LifeTech has established several key collaborations and is currently in discovery and pre-clinical stages of therapeutic development for several genetic diseases.